Emeryville, Calif : NovaBay Pharmaceuticals Inc (NYSE: NBY), on Monday, announces testing results from an independent third party laboratory confirmed that Avenova is very much effective to kills deadly coronavirus. Test results will be submitted to the Environmental protection Agency (EPA) for the EPA’s approved list of disinfectants for use against Covid-19.
NovaBay CEO Justin Bell said “Since Avenova’s inception, we have known it to be powerful antimicrobial spray solution, effective against all types of pathogens, including a wide variety of viruses, bacteria, and fungi. Now we have results from a highly reputable independent laboratory confirming Avenova kills the coronavirus that cause cobid-19” , business wire reported.
Mr. hall added “most COVID-19 transmission is likely due to person-to-person contact as respiratory droplets containing the virus spread through the air by speaking or even breathing and reach others to close proximity. These large droplets transmit the virus by entering the body typically through the eyes, nose or mouth”
“Avenova, formulated with our pure FDA cleared hypochlorous acid, is completely non-toxic and is safe for use on all skin surfaces, including delicate facial skins around eyes, nose and mouth. As a cautionary note, I would like to warn consumers that not all hypochlorous acid products are alike. Some are not designed for use on skin the way Avenova is, and others are not as pure and should not be used on skin on a daily basis. Additionally some hypochlorous acid products are not of a high Pharmaceuticals grade like ours and may not maintain s sufficiently high concentration of hypochlorous acid to kill SARS-CoV-2”
However, after the news NovaBay shares jumps 40% on NYSE just before the opening bell.
Read Also : Google ready to invest $10 billion in India